{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:58:38Z","timestamp":1789556318483,"version":"build-2803163510"},"reference-count":305,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T00:00:00Z","timestamp":1540684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10620-018-5351-6","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T00:23:42Z","timestamp":1540686222000},"page":"324-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis"],"prefix":"10.1007","volume":"64","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo J.","family":"Montano-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,28]]},"reference":[{"key":"5351_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jcb.240490106","volume":"49","author":"JM Lemire","year":"1992","unstructured":"Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992;49:26\u201331.","journal-title":"J Cell Biochem"},{"key":"5351_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u2013281.","journal-title":"N Engl J Med"},{"key":"5351_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/ard.2007.069831","volume":"66","author":"Y Arnson","year":"2007","unstructured":"Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137\u20131142.","journal-title":"Ann Rheum Dis"},{"key":"5351_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncpendmet0716","volume":"4","author":"JS Adams","year":"2008","unstructured":"Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4:80\u201390.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"5351_CR5","doi-asserted-by":"publisher","first-page":"106R","DOI":"10.1203\/PDR.0b013e31819dba91","volume":"65","author":"VP Walker","year":"2009","unstructured":"Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65:106R\u2013113R.","journal-title":"Pediatr Res"},{"key":"5351_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1529-8019.2009.01287.x","volume":"23","author":"J Miller","year":"2010","unstructured":"Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther. 2010;23:13\u201322.","journal-title":"Dermatol Ther"},{"key":"5351_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","volume":"88","author":"DL Kamen","year":"2010","unstructured":"Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441\u2013450.","journal-title":"J Mol Med (Berl)"},{"key":"5351_CR8","first-page":"697","volume":"7","author":"W Dankers","year":"2016","unstructured":"Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2016;7:697.","journal-title":"Front Immunol"},{"key":"5351_CR9","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","volume":"188","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188:2127\u20132135.","journal-title":"J Immunol"},{"key":"5351_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4318\/tjg.2011.0254","volume":"22","author":"S Seydel","year":"2011","unstructured":"Seydel S, Beilfuss A, Kahraman A, et al. Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. Turk J Gastroenterol. 2011;22:400\u2013407.","journal-title":"Turk J Gastroenterol"},{"key":"5351_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2013.06.004","volume":"437","author":"SK Jain","year":"2013","unstructured":"Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun. 2013;437:7\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"5351_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/cen.12449","volume":"81","author":"JA Alvarez","year":"2014","unstructured":"Alvarez JA, Chowdhury R, Jones DP, et al. Vitamin D status is independently associated with plasma glutathione and cysteine thiol\/disulphide redox status in adults. Clin Endocrinol (Oxf). 2014;81:458\u2013466.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5351_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s10620-015-3526-y","volume":"60","author":"Y Beyazit","year":"2015","unstructured":"Beyazit Y, Kocak E, Tanoglu A, Kekilli M. Oxidative stress might play a role in low serum vitamin D associated liver fibrosis among patients with autoimmune hepatitis. Dig Dis Sci. 2015;60:1106\u20131108. https:\/\/doi.org\/10.1007\/s10620-015-3526-y .","journal-title":"Dig Dis Sci"},{"key":"5351_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/gut.2010.234666","volume":"60","author":"S Abramovitch","year":"2011","unstructured":"Abramovitch S, Dahan-Bachar L, Sharvit E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60:1728\u20131737.","journal-title":"Gut"},{"key":"5351_CR15","doi-asserted-by":"publisher","first-page":"G112","DOI":"10.1152\/ajpgi.00132.2013","volume":"308","author":"S Abramovitch","year":"2015","unstructured":"Abramovitch S, Sharvit E, Weisman Y, et al. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2015;308:G112\u2013G120.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5351_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbrc.2015.02.074","volume":"459","author":"FP Reiter","year":"2015","unstructured":"Reiter FP, Hohenester S, Nagel JM, et al. 1,25-(OH)(2)-vitamin D(3) prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-\/-) model. Biochem Biophys Res Commun. 2015;459:227\u2013233.","journal-title":"Biochem Biophys Res Commun"},{"key":"5351_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12026-014-8594-0","volume":"61","author":"N Agmon-Levin","year":"2015","unstructured":"Agmon-Levin N, Kopilov R, Selmi C, et al. Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease. Immunol Res. 2015;61:141\u2013146.","journal-title":"Immunol Res"},{"key":"5351_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cgh.2006.10.015","volume":"5","author":"L Fisher","year":"2007","unstructured":"Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol. 2007;5:513\u2013520.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5351_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12072-010-9194-2","volume":"4","author":"A Miroliaee","year":"2010","unstructured":"Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, et al. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int. 2010;4:634\u2013640.","journal-title":"Hepatol Int"},{"key":"5351_CR20","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1007\/s10620-009-1069-9","volume":"55","author":"J Arteh","year":"2010","unstructured":"Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2010;55:2624\u20132628. https:\/\/doi.org\/10.1007\/s10620-009-1069-9 .","journal-title":"Dig Dis Sci"},{"key":"5351_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/liv.12106","volume":"33","author":"CS Stokes","year":"2013","unstructured":"Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int. 2013;33:338\u2013352.","journal-title":"Liver Int"},{"key":"5351_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S1499-3872(14)60295-2","volume":"13","author":"EQ Chen","year":"2014","unstructured":"Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int. 2014;13:580\u2013585.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"5351_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/hep.26962","volume":"60","author":"C Efe","year":"2014","unstructured":"Efe C, Purnak T, Ozaslan E. Vitamin D levels in patients with chronic hepatitis B. Hepatology. 2014;60:768.","journal-title":"Hepatology"},{"key":"5351_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.26488","volume":"58","author":"H Farnik","year":"2013","unstructured":"Farnik H, Bojunga J, Berger A, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013;58:1270\u20131276.","journal-title":"Hepatology"},{"key":"5351_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4254\/wjh.v6.i12.901","volume":"6","author":"P Iruzubieta","year":"2014","unstructured":"Iruzubieta P, Teran A, Crespo J, Fabrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol. 2014;6:901\u2013915.","journal-title":"World J Hepatol"},{"key":"5351_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/CIA.S104599","volume":"11","author":"SA Gabr","year":"2016","unstructured":"Gabr SA, Alghadir AH, Allam AA, et al. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4. Clin Interv Aging. 2016;11:523\u2013533.","journal-title":"Clin Interv Aging"},{"key":"5351_CR27","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.23489","volume":"51","author":"S Petta","year":"2010","unstructured":"Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51:1158\u20131167.","journal-title":"Hepatology"},{"key":"5351_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/jc.2014-2741","volume":"100","author":"S Petta","year":"2015","unstructured":"Petta S, Grimaudo S, Tripodo C, et al. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients. J Clin Endocrinol Metab. 2015;100:193\u2013200.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR29","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1111\/liv.12312","volume":"34","author":"J Dasarathy","year":"2014","unstructured":"Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34:e118\u2013e127.","journal-title":"Liver Int"},{"key":"5351_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ajg.2016.51","volume":"111","author":"JE Nelson","year":"2016","unstructured":"Nelson JE, Roth CL, Wilson LA, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-kappaB? Am J Gastroenterol. 2016;111:852\u2013863.","journal-title":"Am J Gastroenterol"},{"key":"5351_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1590\/S0004-28032009000100016","volume":"46","author":"ML Saron","year":"2009","unstructured":"Saron ML, Godoy HT, Hessel G. Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D and E. Arq Gastroenterol. 2009;46:62\u201368.","journal-title":"Arq Gastroenterol"},{"key":"5351_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.clinre.2013.05.016","volume":"37","author":"DS Smyk","year":"2013","unstructured":"Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013;37:535\u2013545.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"5351_CR33","first-page":"407","volume":"5","author":"KV Luong","year":"2013","unstructured":"Luong KV, Nguyen LT. The role of vitamin D in autoimmune hepatitis. J Clin Med Res. 2013;5:407\u2013415.","journal-title":"J Clin Med Res"},{"key":"5351_CR34","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","volume":"59","author":"C Efe","year":"2014","unstructured":"Efe C, Kav T, Aydin C, et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci. 2014;59:3035\u20133042. https:\/\/doi.org\/10.1007\/s10620-014-3267-3 .","journal-title":"Dig Dis Sci"},{"key":"5351_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44:1687\u20131692.","journal-title":"Neurology"},{"key":"5351_CR36","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832\u20132838.","journal-title":"JAMA"},{"key":"5351_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1055\/s-2005-870578","volume":"37","author":"P Pozzilli","year":"2005","unstructured":"Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37:680\u2013683.","journal-title":"Horm Metab Res"},{"key":"5351_CR38","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00125-006-0426-x","volume":"49","author":"B Littorin","year":"2006","unstructured":"Littorin B, Blom P, Scholin A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49:2847\u20132852.","journal-title":"Diabetologia"},{"key":"5351_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00592-008-0071-6","volume":"46","author":"A Bener","year":"2009","unstructured":"Bener A, Alsaied A, Al-Ali M, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009;46:183\u2013189.","journal-title":"Acta Diabetol"},{"key":"5351_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jpeds.2008.07.015","volume":"154","author":"BM Svoren","year":"2009","unstructured":"Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009;154:132\u2013134.","journal-title":"J Pediatr"},{"key":"5351_CR41","doi-asserted-by":"crossref","first-page":"w13091","DOI":"10.4414\/smw.2010.13091","volume":"140","author":"M Janner","year":"2010","unstructured":"Janner M, Ballinari P, Mullis PE, Fluck CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly. 2010;140:w13091.","journal-title":"Swiss Med Wkly"},{"key":"5351_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1399-5448.2009.00589.x","volume":"11","author":"VV Borkar","year":"2010","unstructured":"Borkar VV, Devidayal, Verma S, Bhalla AK. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2010;11:345\u2013350.","journal-title":"Pediatr Diabetes"},{"key":"5351_CR43","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.diabres.2014.12.008","volume":"108","author":"R Feng","year":"2015","unstructured":"Feng R, Li Y, Li G, et al. Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2015;108:e71\u2013e75.","journal-title":"Diabetes Res Clin Pract"},{"key":"5351_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.6065\/apem.2018.23.1.21","volume":"23","author":"KN Bae","year":"2018","unstructured":"Bae KN, Nam HK, Rhie YJ, Song DJ, Lee KH. Low levels of 25-hydroxyvitamin D in children and adolescents with type 1 diabetes mellitus: a single center experience. Ann Pediatr Endocrinol Metab. 2018;23:21\u201327.","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"5351_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/BF02201030","volume":"6","author":"OS Als","year":"1987","unstructured":"Als OS, Riis B, Christiansen C. Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol. 1987;6:238\u2013243.","journal-title":"Clin Rheumatol"},{"key":"5351_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s002239900416","volume":"62","author":"P Oelzner","year":"1998","unstructured":"Oelzner P, Muller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998;62:193\u2013198.","journal-title":"Calcif Tissue Int"},{"key":"5351_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/03009749309099266","volume":"22","author":"H Kroger","year":"1993","unstructured":"Kroger H, Penttila IM, Alhava EM. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol. 1993;22:172\u2013177.","journal-title":"Scand J Rheumatol"},{"key":"5351_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s001980070052","volume":"11","author":"P Aguado","year":"2000","unstructured":"Aguado P, del Campo MT, Garces MV, et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int. 2000;11:739\u2013744.","journal-title":"Osteoporos Int"},{"key":"5351_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/jnsbm.JNSBM_128_17","volume":"9","author":"N Meena","year":"2018","unstructured":"Meena N, Singh Chawla SP, Garg R, Batta A, Kaur S. Assessment of vitamin D in rheumatoid arthritis and its correlation with disease activity. J Nat Sci Biol Med. 2018;9:54\u201358.","journal-title":"J Nat Sci Biol Med"},{"key":"5351_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-00018-00426-00395","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wen H. Impact of vitamin D deficiency on clinical parameters in treatment-naive rheumatoid arthritis patients. Z Rheumatol. 2018. https:\/\/doi.org\/10.1007\/s00393-00018-00426-00395 .","journal-title":"Z Rheumatol"},{"key":"5351_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/003655202753416876","volume":"37","author":"J Jahnsen","year":"2002","unstructured":"Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192\u2013199.","journal-title":"Scand J Gastroenterol"},{"key":"5351_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.17219\/acem\/37208","volume":"23","author":"A Kosmowska-Miskow","year":"2014","unstructured":"Kosmowska-Miskow A. The role of vitamin D3 in inflammatory bowel diseases. Adv Clin Exp Med. 2014;23:497\u2013504.","journal-title":"Adv Clin Exp Med"},{"key":"5351_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","volume":"5","author":"DL Kamen","year":"2006","unstructured":"Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5:114\u2013117.","journal-title":"Autoimmun Rev"},{"key":"5351_CR54","first-page":"1","volume":"24","author":"E Farid","year":"2017","unstructured":"Farid E, Jaradat AA, Al-Segai O, Hassan AB. Prevalence of vitamin D deficiency in adult patients with systemic lupus erythematosus in Kingdom of Bahrain. Egypt J Immunol. 2017;24:1\u20138.","journal-title":"Egypt J Immunol"},{"key":"5351_CR55","first-page":"1","volume":"9","author":"T Hassanalilou","year":"2017","unstructured":"Hassanalilou T, Khalili L, Ghavamzadeh S, et al. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Auto Immun Highlights. 2017;9:1.","journal-title":"Auto Immun Highlights"},{"key":"5351_CR56","doi-asserted-by":"publisher","first-page":"e0170323","DOI":"10.1371\/journal.pone.0170323","volume":"12","author":"M Eloi","year":"2017","unstructured":"Eloi M, Horvath DV, Ortega JC, et al. 25-Hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS ONE. 2017;12:e0170323.","journal-title":"PLoS ONE"},{"key":"5351_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14715\/cmb\/2018.64.1.2","volume":"64","author":"SC Bae","year":"2018","unstructured":"Bae SC, Lee YH. Association between Vitamin D level and\/or deficiency, and systemic lupus erythematosus: a meta-analysis. Cell Mol Biol (Noisy-le-grand). 2018;64:7\u201313.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"5351_CR58","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/nu7042485","volume":"7","author":"J Wang","year":"2015","unstructured":"Wang J, Lv S, Chen G, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7:2485\u20132498.","journal-title":"Nutrients"},{"key":"5351_CR59","first-page":"297","volume":"29","author":"C Konstantakis","year":"2016","unstructured":"Konstantakis C, Tselekouni P, Kalafateli M, Triantos C. Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol. 2016;29:297\u2013306.","journal-title":"Ann Gastroenterol"},{"key":"5351_CR60","doi-asserted-by":"publisher","first-page":"e0132119","DOI":"10.1371\/journal.pone.0132119","volume":"10","author":"F Finkelmeier","year":"2015","unstructured":"Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O. Low 25-hydroxyvitamin D levels are associated with infections and mortality in patients with cirrhosis. PLoS ONE. 2015;10:e0132119.","journal-title":"PLoS ONE"},{"key":"5351_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/eci.12205","volume":"44","author":"CS Stokes","year":"2014","unstructured":"Stokes CS, Krawczyk M, Reichel C, Lammert F, Grunhage F. Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis. Eur J Clin Invest. 2014;44:176\u2013183.","journal-title":"Eur J Clin Invest"},{"key":"5351_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd3318","volume":"9","author":"LA Plum","year":"2010","unstructured":"Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941\u2013955.","journal-title":"Nat Rev Drug Discov"},{"key":"5351_CR63","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991;87:1103\u20131107.","journal-title":"J Clin Invest"},{"key":"5351_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0165-5728(95)00076-E","volume":"61","author":"DD Branisteanu","year":"1995","unstructured":"Branisteanu DD, Waer M, Sobis H, et al. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol. 1995;61:151\u2013160.","journal-title":"J Neuroimmunol"},{"key":"5351_CR65","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","volume":"93","author":"MT Cantorna","year":"1996","unstructured":"Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996;93:7861\u20137864.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jn\/128.1.68","volume":"128","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128:68\u201372.","journal-title":"J Nutr"},{"key":"5351_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/08916939209150321","volume":"12","author":"JM Lemire","year":"1992","unstructured":"Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice. Autoimmunity. 1992;12:143\u2013148.","journal-title":"Autoimmunity"},{"key":"5351_CR68","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/diab.41.11.1491","volume":"41","author":"C Mathieu","year":"1992","unstructured":"Mathieu C, Laureys J, Sobis H, et al. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes. 1992;41:1491\u20131495.","journal-title":"Diabetes"},{"key":"5351_CR69","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/BF00403372","volume":"37","author":"C Mathieu","year":"1994","unstructured":"Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994;37:552\u2013558.","journal-title":"Diabetologia"},{"key":"5351_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0003-9861(03)00338-2","volume":"417","author":"JB Zella","year":"2003","unstructured":"Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003;417:77\u201380.","journal-title":"Arch Biochem Biophys"},{"key":"5351_CR71","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/jn\/130.11.2648","volume":"130","author":"MT Cantorna","year":"2000","unstructured":"Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130:2648\u20132652.","journal-title":"J Nutr"},{"key":"5351_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/eji.200425491","volume":"35","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005;35:217\u2013224.","journal-title":"Eur J Immunol"},{"key":"5351_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.imlet.2010.03.006","volume":"131","author":"G Laverny","year":"2010","unstructured":"Laverny G, Penna G, Vetrano S, et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett. 2010;131:49\u201358.","journal-title":"Immunol Lett"},{"key":"5351_CR74","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/apm.12378","volume":"123","author":"H Zhang","year":"2015","unstructured":"Zhang H, Wu H, Liu L, et al. 1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation. APMIS. 2015;123:490\u2013501.","journal-title":"APMIS"},{"key":"5351_CR75","first-page":"453","volume":"17","author":"Z Andjelkovic","year":"1999","unstructured":"Andjelkovic Z, Vojinovic J, Pejnovic N, et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol. 1999;17:453\u2013456.","journal-title":"Clin Exp Rheumatol"},{"key":"5351_CR76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","volume":"32","author":"SP Jorgensen","year":"2010","unstructured":"Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn\u2019s disease\u2014a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377\u2013383.","journal-title":"Aliment Pharmacol Ther"},{"key":"5351_CR77","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"AS Dusso","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8\u2013F28.","journal-title":"Am J Physiol Renal Physiol"},{"key":"5351_CR78","doi-asserted-by":"publisher","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S\u20131696S.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR79","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0006-291X(77)91674-6","volume":"76","author":"MF Holick","year":"1977","unstructured":"Holick MF, Frommer JE, McNeill SC, et al. Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun. 1977;76:107\u2013114.","journal-title":"Biochem Biophys Res Commun"},{"key":"5351_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3177\/jnsv.23.165","volume":"23","author":"T Okano","year":"1977","unstructured":"Okano T, Yasumura M, Mizuno K, Kobayashi T. Photochemical conversion of 7-dehydrocholesterol into vitamin D3 in rat skins. J Nutr Sci Vitaminol (Tokyo). 1977;23:165\u2013168.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"5351_CR81","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.0402490101","volume":"101","author":"JB Cheng","year":"2004","unstructured":"Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA. 2004;101:7711\u20137715.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR82","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1210\/jcem-63-4-954","volume":"63","author":"DD Bikle","year":"1986","unstructured":"Bikle DD, Gee E, Halloran B, et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63:954\u2013959.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR83","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ecl.2017.07.003","volume":"46","author":"LM Smith","year":"2017","unstructured":"Smith LM, Gallagher JC. Dietary vitamin D intake for the elderly population: update on the recommended dietary allowance for vitamin D. Endocrinol Metab Clin North Am. 2017;46:871\u2013884.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5351_CR84","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S0140-6736(89)91124-0","volume":"2","author":"MF Holick","year":"1989","unstructured":"Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet. 1989;2:1104\u20131105.","journal-title":"Lancet"},{"key":"5351_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-77574-6_1","volume":"624","author":"MF Holick","year":"2008","unstructured":"Holick MF. Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol. 2008;624:1\u201315.","journal-title":"Adv Exp Med Biol"},{"key":"5351_CR86","doi-asserted-by":"publisher","first-page":"e0181063","DOI":"10.1371\/journal.pone.0181063","volume":"12","author":"CH Huang","year":"2017","unstructured":"Huang CH, Huang YA, Lai YC, Sun CK. Prevalence and predictors of hypovitaminosis D among the elderly in subtropical region. PLoS ONE. 2017;12:e0181063.","journal-title":"PLoS ONE"},{"key":"5351_CR87","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/228764a0","volume":"228","author":"DR Fraser","year":"1970","unstructured":"Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970;228:764\u2013766.","journal-title":"Nature"},{"key":"5351_CR88","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/276287a0","volume":"276","author":"MG Brunette","year":"1978","unstructured":"Brunette MG, Chan M, Ferriere C, Roberts KD. Site of 1,25(OH)2 vitamin D3 synthesis in the kidney. Nature. 1978;276:287\u2013289.","journal-title":"Nature"},{"key":"5351_CR89","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1073\/pnas.131029498","volume":"98","author":"DK Panda","year":"2001","unstructured":"Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA. 2001;98:7498\u20137503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR90","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/endo.140.5.6683","volume":"140","author":"R Bland","year":"1999","unstructured":"Bland R, Walker EA, Hughes SV, Stewart PM, Hewison M. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology. 1999;140:2027\u20132034.","journal-title":"Endocrinology"},{"key":"5351_CR91","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","volume":"142","author":"O Dardenne","year":"2001","unstructured":"Dardenne O, Prud\u2019homme J, Arabian A, Glorieux FH, St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 2001;142:3135\u20133141.","journal-title":"Endocrinology"},{"key":"5351_CR92","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","volume":"78","author":"G Jones","year":"1998","unstructured":"Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78:1193\u20131231.","journal-title":"Physiol Rev"},{"key":"5351_CR93","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2169\/internalmedicine.47.0730","volume":"47","author":"S Fukumoto","year":"2008","unstructured":"Fukumoto S. Physiological regulation and disorders of phosphate metabolism\u2013pivotal role of fibroblast growth factor 23. Intern Med. 2008;47:337\u2013343.","journal-title":"Intern Med"},{"key":"5351_CR94","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008;118:3820\u20133828.","journal-title":"J Clin Invest"},{"key":"5351_CR95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ecl.2010.02.002","volume":"39","author":"S Christakos","year":"2010","unstructured":"Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am. 2010;39:243\u2013253 (table of contents).","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5351_CR96","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96:365\u2013408.","journal-title":"Physiol Rev"},{"key":"5351_CR97","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2741\/1514","volume":"10","author":"T Sakaki","year":"2005","unstructured":"Sakaki T, Kagawa N, Yamamoto K, Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci. 2005;10:119\u2013134.","journal-title":"Front Biosci"},{"key":"5351_CR98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1194\/jlr.R031534","volume":"55","author":"G Jones","year":"2014","unstructured":"Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res. 2014;55:13\u201331.","journal-title":"J Lipid Res"},{"key":"5351_CR99","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1021\/acschembio.6b00569","volume":"11","author":"OB Yu","year":"2016","unstructured":"Yu OB, Arnold LA. Calcitroic acid\u2014a review. ACS Chem Biol. 2016;11:2665\u20132672.","journal-title":"ACS Chem Biol"},{"key":"5351_CR100","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJM198108203050807","volume":"305","author":"GL Barbour","year":"1981","unstructured":"Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981;305:440\u2013443.","journal-title":"N Engl J Med"},{"key":"5351_CR101","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1172\/JCI111147","volume":"72","author":"JS Adams","year":"1983","unstructured":"Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983;72:1856\u20131860.","journal-title":"J Clin Invest"},{"key":"5351_CR102","first-page":"888","volume":"86","author":"D Zehnder","year":"2001","unstructured":"Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888\u2013894.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR103","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","volume":"57","author":"AK Bhalla","year":"1983","unstructured":"Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57:1308\u20131310.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR104","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1126\/science.6310748","volume":"221","author":"DM Provvedini","year":"1983","unstructured":"Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221:1181\u20131183.","journal-title":"Science"},{"key":"5351_CR105","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/abbi.1999.1605","volume":"374","author":"CM Veldman","year":"2000","unstructured":"Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374:334\u2013338.","journal-title":"Arch Biochem Biophys"},{"key":"5351_CR106","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634\u20131647.","journal-title":"J Immunol"},{"key":"5351_CR107","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","volume":"178","author":"G Penna","year":"2007","unstructured":"Penna G, Amuchastegui S, Giarratana N, et al. 1,25-dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol. 2007;178:145\u2013153.","journal-title":"J Immunol"},{"key":"5351_CR108","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s10620-014-3473-z","volume":"60","author":"AJ Montano-Loza","year":"2014","unstructured":"Montano-Loza AJ, Czaja AJ. Cell mediators of autoimmune hepatitis and their therapeutic implications. Dig Dis Sci. 2014;60:1528\u20131542. https:\/\/doi.org\/10.1007\/s10620-014-3473-z .","journal-title":"Dig Dis Sci"},{"key":"5351_CR109","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","volume":"13","author":"MR Haussler","year":"1998","unstructured":"Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325\u2013349.","journal-title":"J Bone Miner Res"},{"key":"5351_CR110","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2013.00148","volume":"4","author":"M Kongsbak","year":"2013","unstructured":"Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Front Immunol. 2013;4:148.","journal-title":"Front Immunol"},{"key":"5351_CR111","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/nu7095383","volume":"7","author":"M Barragan","year":"2015","unstructured":"Barragan M, Good M, Kolls JK. Regulation of dendritic cell function by vitamin D. Nutrients. 2015;7:8127\u20138151.","journal-title":"Nutrients"},{"key":"5351_CR112","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.136.8.2734","volume":"136","author":"DM Provvedini","year":"1986","unstructured":"Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1 Alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol. 1986;136:2734\u20132740.","journal-title":"J Immunol"},{"key":"5351_CR113","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1210\/jcem-67-3-607","volume":"67","author":"U Berger","year":"1988","unstructured":"Berger U, Wilson P, McClelland RA, et al. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988;67:607\u2013613.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR114","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM198904133201506","volume":"320","author":"H Reichel","year":"1989","unstructured":"Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989;320:980\u2013991.","journal-title":"N Engl J Med"},{"key":"5351_CR115","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1073\/pnas.0711558105","volume":"105","author":"S Yu","year":"2008","unstructured":"Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA. 2008;105:5207\u20135212.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR116","doi-asserted-by":"publisher","first-page":"20834","DOI":"10.1073\/pnas.0808700106","volume":"105","author":"S Yu","year":"2008","unstructured":"Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4\/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA. 2008;105:20834\u201320839.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR117","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.1003444","volume":"186","author":"D Bruce","year":"2011","unstructured":"Bruce D, Cantorna MT. Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells. J Immunol. 2011;186:2819\u20132825.","journal-title":"J Immunol"},{"key":"5351_CR118","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.2010.05823.x","volume":"1217","author":"MT Cantorna","year":"2011","unstructured":"Cantorna MT. Why do T cells express the vitamin D receptor? Ann N Y Acad Sci. 2011;1217:77\u201382.","journal-title":"Ann N Y Acad Sci"},{"key":"5351_CR119","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1084\/jem.194.12.1801","volume":"194","author":"AK Singh","year":"2001","unstructured":"Singh AK, Wilson MT, Hong S, et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001;194:1801\u20131811.","journal-title":"J Exp Med"},{"key":"5351_CR120","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1084\/jem.20011793","volume":"195","author":"P Poussier","year":"2002","unstructured":"Poussier P, Ning T, Banerjee D, Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med. 2002;195:1491\u20131497.","journal-title":"J Exp Med"},{"key":"5351_CR121","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fimmu.2013.00223","volume":"4","author":"LJ Walker","year":"2013","unstructured":"Walker LJ, Marrinan E, Muenchhoff M, et al. CD8alphaalpha expression marks terminally differentiated human CD8+ T cells expanded in chronic viral infection. Front Immunol. 2013;4:223.","journal-title":"Front Immunol"},{"key":"5351_CR122","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ni.1851","volume":"11","author":"MR Essen von","year":"2010","unstructured":"von Essen MR, Kongsbak M, Schjerling P, et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11:344\u2013349.","journal-title":"Nat Immunol"},{"key":"5351_CR123","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.humimm.2012.04.019","volume":"73","author":"RW Joseph","year":"2012","unstructured":"Joseph RW, Bayraktar UD, Kim TK, et al. Vitamin D receptor upregulation in alloreactive human T cells. Hum Immunol. 2012;73:693\u2013698.","journal-title":"Hum Immunol"},{"key":"5351_CR124","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1128\/MCB.15.10.5789","volume":"15","author":"I Alroy","year":"1995","unstructured":"Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp\/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995;15:5789\u20135799.","journal-title":"Mol Cell Biol"},{"key":"5351_CR125","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.6427923","volume":"224","author":"DA Cantrell","year":"1984","unstructured":"Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science. 1984;224:1312\u20131316.","journal-title":"Science"},{"key":"5351_CR126","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1126\/science.3131876","volume":"240","author":"KA Smith","year":"1988","unstructured":"Smith KA. Interleukin-2: inception, impact, and implications. Science. 1988;240:1169\u20131176.","journal-title":"Science"},{"key":"5351_CR127","doi-asserted-by":"publisher","first-page":"e12899","DOI":"10.1111\/eci.12899","volume":"48","author":"AJ Czaja","year":"2018","unstructured":"Czaja AJ. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018;48:e12899.","journal-title":"Eur J Clin Invest"},{"key":"5351_CR128","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/hep.27131","volume":"60","author":"DA Mann","year":"2014","unstructured":"Mann DA. Epigenetics in liver disease. Hepatology. 2014;60:1418\u20131425.","journal-title":"Hepatology"},{"key":"5351_CR129","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1128\/MCB.16.3.1006","volume":"16","author":"BD Lemon","year":"1996","unstructured":"Lemon BD, Freedman LP. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol. 1996;16:1006\u20131016.","journal-title":"Mol Cell Biol"},{"key":"5351_CR130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02782754","volume":"4","author":"C Carlberg","year":"1996","unstructured":"Carlberg C. The vitamin D(3) receptor in the context of the nuclear receptor superfamily: the central role of the retinoid X receptor. Endocrine. 1996;4:91\u2013105.","journal-title":"Endocrine"},{"key":"5351_CR131","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/jmbi.2000.3499","volume":"296","author":"M Quack","year":"2000","unstructured":"Quack M, Carlberg C. Ligand-triggered stabilization of vitamin D receptor\/retinoid X receptor heterodimer conformations on DR4-type response elements. J Mol Biol. 2000;296:743\u2013756.","journal-title":"J Mol Biol"},{"key":"5351_CR132","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ecl.2010.02.007","volume":"39","author":"JW Pike","year":"2010","unstructured":"Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010;39:255\u2013269 (table of contents).","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5351_CR133","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1359\/JBMR.041112","volume":"20","author":"S Kim","year":"2005","unstructured":"Kim S, Shevde NK, Pike JW. 1,25-dihydroxyvitamin D3 stimulates cyclic vitamin D receptor\/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res. 2005;20:305\u2013317.","journal-title":"J Bone Miner Res"},{"key":"5351_CR134","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/eji.200636043","volume":"37","author":"E Etten van","year":"2007","unstructured":"van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37:395\u2013405.","journal-title":"Eur J Immunol"},{"key":"5351_CR135","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/jhep.2002.30084","volume":"35","author":"A Vogel","year":"2002","unstructured":"Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35:126\u2013131.","journal-title":"Hepatology"},{"key":"5351_CR136","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","volume":"20","author":"L Fan","year":"2005","unstructured":"Fan L, Tu X, Zhu Y, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol. 2005;20:249\u2013255.","journal-title":"J Gastroenterol Hepatol"},{"key":"5351_CR137","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cytogfr.2014.07.017","volume":"25","author":"AL Croxford","year":"2014","unstructured":"Croxford AL, Kulig P, Becher B. IL-12-and IL-23 in health and disease. Cytokine Growth Factor Rev. 2014;25:415\u2013421.","journal-title":"Cytokine Growth Factor Rev"},{"key":"5351_CR138","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/MCB.05020-11","volume":"31","author":"S Joshi","year":"2011","unstructured":"Joshi S, Pantalena LC, Liu XK, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31:3653\u20133669.","journal-title":"Mol Cell Biol"},{"key":"5351_CR139","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.0403147","volume":"75","author":"M Zanetti","year":"2004","unstructured":"Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39\u201348.","journal-title":"J Leukoc Biol"},{"key":"5351_CR140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9","volume":"55","author":"R Gennaro","year":"2000","unstructured":"Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers. 2000;55:31\u201349.","journal-title":"Biopolymers"},{"key":"5351_CR141","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770\u20131773.","journal-title":"Science"},{"key":"5351_CR142","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"TT Wang","year":"2004","unstructured":"Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909\u20132912.","journal-title":"J Immunol"},{"key":"5351_CR143","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","volume":"60","author":"AJ Czaja","year":"2015","unstructured":"Czaja AJ. Transitioning from idiopathic to explainable autoimmune hepatitis. Dig Dis Sci. 2015;60:2881\u20132900. https:\/\/doi.org\/10.1007\/s10620-015-3708-7 .","journal-title":"Dig Dis Sci"},{"key":"5351_CR144","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/apt.14324","volume":"46","author":"AJ Czaja","year":"2017","unstructured":"Czaja AJ. Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Aliment Pharmacol Ther. 2017;46:920\u2013937.","journal-title":"Aliment Pharmacol Ther"},{"key":"5351_CR145","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","volume":"79","author":"K McKenna","year":"2005","unstructured":"McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol. 2005;79:17\u201327.","journal-title":"J Virol"},{"key":"5351_CR146","doi-asserted-by":"publisher","first-page":"857143","DOI":"10.1155\/2014\/857143","volume":"2014","author":"J Mbongue","year":"2014","unstructured":"Mbongue J, Nicholas D, Firek A, Langridge W. The role of dendritic cells in tissue-specific autoimmunity. J Immunol Res. 2014;2014:857143.","journal-title":"J Immunol Res"},{"key":"5351_CR147","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","volume":"164","author":"G Penna","year":"2000","unstructured":"Penna G, Adorini L. 1 alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164:2405\u20132411.","journal-title":"J Immunol"},{"key":"5351_CR148","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4049\/jimmunol.174.1.270","volume":"174","author":"MC Gauzzi","year":"2005","unstructured":"Gauzzi MC, Purificato C, Donato K, et al. Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol. 2005;174:270\u2013276.","journal-title":"J Immunol"},{"key":"5351_CR149","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaut.2004.06.004","volume":"23","author":"AG Halteren van","year":"2004","unstructured":"van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO. 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun. 2004;23:233\u2013239.","journal-title":"J Autoimmun"},{"key":"5351_CR150","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1172\/JCI1050","volume":"101","author":"D D\u2019Ambrosio","year":"1998","unstructured":"D\u2019Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest. 1998;101:252\u2013262.","journal-title":"J Clin Invest"},{"key":"5351_CR151","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","volume":"46","author":"K Hudspeth","year":"2013","unstructured":"Hudspeth K, Pontarini E, Tentorio P, et al. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun. 2013;46:55\u201365.","journal-title":"J Autoimmun"},{"key":"5351_CR152","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331:44\u201349.","journal-title":"Science"},{"key":"5351_CR153","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.immuni.2012.03.026","volume":"36","author":"RS Goldszmid","year":"2012","unstructured":"Goldszmid RS, Caspar P, Rivollier A, et al. NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity. 2012;36:1047\u20131059.","journal-title":"Immunity"},{"key":"5351_CR154","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.182.3.875","volume":"182","author":"A Moretta","year":"1995","unstructured":"Moretta A, Sivori S, Vitale M, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 1995;182:875\u2013884.","journal-title":"J Exp Med"},{"key":"5351_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","volume":"149","author":"RJ Boyton","year":"2007","unstructured":"Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149:1\u20138.","journal-title":"Clin Exp Immunol"},{"key":"5351_CR156","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jnutbio.2018.01.004","volume":"55","author":"GY Lee","year":"2018","unstructured":"Lee GY, Park CY, Cha KS, et al. Differential effect of dietary vitamin D supplementation on natural killer cell activity in lean and obese mice. J Nutr Biochem. 2018;55:178\u2013184.","journal-title":"J Nutr Biochem"},{"key":"5351_CR157","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V76.1.189.189","volume":"76","author":"WF Rigby","year":"1990","unstructured":"Rigby WF, Waugh M, Graziano RF. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood. 1990;76:189\u2013197.","journal-title":"Blood"},{"key":"5351_CR158","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.135.4.2279","volume":"135","author":"WF Rigby","year":"1985","unstructured":"Rigby WF, Noelle RJ, Krause K, Fanger MW. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol. 1985;135:2279\u20132286.","journal-title":"J Immunol"},{"key":"5351_CR159","first-page":"3739","volume":"84","author":"M Willheim","year":"1999","unstructured":"Willheim M, Thien R, Schrattbauer K, et al. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab. 1999;84:3739\u20133744.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR160","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/nu7043011","volume":"7","author":"MT Cantorna","year":"2015","unstructured":"Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7:3011\u20133021.","journal-title":"Nutrients"},{"key":"5351_CR161","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1074\/jbc.273.17.10338","volume":"273","author":"TL Towers","year":"1998","unstructured":"Towers TL, Freedman LP. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem. 1998;273:10338\u201310348.","journal-title":"J Biol Chem"},{"key":"5351_CR162","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1128\/MCB.19.6.4191","volume":"19","author":"TL Towers","year":"1999","unstructured":"Towers TL, Staeva TP, Freedman LP. A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol Cell Biol. 1999;19:4191\u20134199.","journal-title":"Mol Cell Biol"},{"key":"5351_CR163","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","volume":"167","author":"A Boonstra","year":"2001","unstructured":"Boonstra A, Barrat FJ, Crain C, et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974\u20134980.","journal-title":"J Immunol"},{"key":"5351_CR164","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.intimp.2007.09.016","volume":"7","author":"LE Bartels","year":"2007","unstructured":"Bartels LE, Jorgensen SP, Agnholt J, et al. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4\u2009+\u2009T cells from patients with Crohn\u2019s disease. Int Immunopharmacol. 2007;7:1755\u20131764.","journal-title":"Int Immunopharmacol"},{"key":"5351_CR165","doi-asserted-by":"publisher","first-page":"e0131539","DOI":"10.1371\/journal.pone.0131539","volume":"10","author":"LE Jeffery","year":"2015","unstructured":"Jeffery LE, Qureshi OS, Gardner D, et al. Vitamin D antagonises the suppressive effect of inflammatory cytokines on CTLA-4 expression and regulatory function. PLoS ONE. 2015;10:e0131539.","journal-title":"PLoS ONE"},{"key":"5351_CR166","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/iub.1349","volume":"67","author":"R Liberal","year":"2015","unstructured":"Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Regulatory T cells: mechanisms of suppression and impairment in autoimmune liver disease. IUBMB Life. 2015;67:88\u201397.","journal-title":"IUBMB Life"},{"key":"5351_CR167","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol. 2003;4:330\u2013336.","journal-title":"Nat Immunol"},{"key":"5351_CR168","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057\u20131061.","journal-title":"Science"},{"key":"5351_CR169","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4\u2009+\u2009T reg cells. J Exp Med. 2006;203:1701\u20131711.","journal-title":"J Exp Med"},{"key":"5351_CR170","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225\u20131232.","journal-title":"Blood"},{"key":"5351_CR171","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","volume":"167","author":"S Gregori","year":"2001","unstructured":"Gregori S, Casorati M, Amuchastegui S, et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001;167:1945\u20131953.","journal-title":"J Immunol"},{"key":"5351_CR172","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","volume":"51","author":"S Gregori","year":"2002","unstructured":"Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367\u20131374.","journal-title":"Diabetes"},{"key":"5351_CR173","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.4049\/jimmunol.1302350","volume":"192","author":"GB Ferreira","year":"2014","unstructured":"Ferreira GB, Gysemans CA, Demengeot J, et al. 1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol. 2014;192:4210\u20134220.","journal-title":"J Immunol"},{"key":"5351_CR174","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","volume":"106","author":"G Penna","year":"2005","unstructured":"Penna G, Roncari A, Amuchastegui S, et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+ Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood. 2005;106:3490\u20133497.","journal-title":"Blood"},{"key":"5351_CR175","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4049\/jimmunol.166.2.996","volume":"166","author":"S Sebastiani","year":"2001","unstructured":"Sebastiani S, Allavena P, Albanesi C, et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol. 2001;166:996\u20131002.","journal-title":"J Immunol"},{"key":"5351_CR176","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","volume":"183","author":"JM Fletcher","year":"2009","unstructured":"Fletcher JM, Lonergan R, Costelloe L, et al. CD39+ Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol. 2009;183:7602\u20137610.","journal-title":"J Immunol"},{"key":"5351_CR177","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31\u201337.","journal-title":"J Hepatol"},{"key":"5351_CR178","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1172\/JCI111465","volume":"74","author":"JM Lemire","year":"1984","unstructured":"Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984;74:657\u2013661.","journal-title":"J Clin Invest"},{"key":"5351_CR179","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.4049\/jimmunol.136.12.4427","volume":"136","author":"S Iho","year":"1986","unstructured":"Iho S, Takahashi T, Kura F, Sugiyama H, Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol. 1986;136:4427\u20134431.","journal-title":"J Immunol"},{"key":"5351_CR180","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clim.2008.01.011","volume":"127","author":"SN Liossis","year":"2008","unstructured":"Liossis SN, Sfikakis PP. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol. 2008;127:280\u2013285.","journal-title":"Clin Immunol"},{"key":"5351_CR181","doi-asserted-by":"publisher","first-page":"25260","DOI":"10.1074\/jbc.M311052200","volume":"279","author":"P Li","year":"2004","unstructured":"Li P, Li C, Zhao X, et al. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E\/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein\/Skp2 ubiquitin ligase. J Biol Chem. 2004;279:25260\u201325267.","journal-title":"J Biol Chem"},{"key":"5351_CR182","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1191\/0961203304lu1014oa","volume":"13","author":"T Dorner","year":"2004","unstructured":"Dorner T, Lipsky PE. Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus. 2004;13:283\u2013289.","journal-title":"Lupus"},{"key":"5351_CR183","doi-asserted-by":"crossref","first-page":"1704S","DOI":"10.1093\/jn\/125.suppl_6.1704S","volume":"125","author":"JM Lemire","year":"1995","unstructured":"Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125:1704S\u20131708S.","journal-title":"J Nutr"},{"key":"5351_CR184","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2337\/diabetes.49.8.1301","volume":"49","author":"L Overbergh","year":"2000","unstructured":"Overbergh L, Decallonne B, Waer M, et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1\/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes. 2000;49:1301\u20131307.","journal-title":"Diabetes"},{"key":"5351_CR185","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/sj.onc.1204386","volume":"20","author":"F Macian","year":"2001","unstructured":"Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 2001;20:2476\u20132489.","journal-title":"Oncogene"},{"key":"5351_CR186","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5:472\u2013484.","journal-title":"Nat Rev Immunol"},{"key":"5351_CR187","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132:1146\u20131160.","journal-title":"Brain"},{"key":"5351_CR188","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/art.25043","volume":"62","author":"EM Colin","year":"2010","unstructured":"Colin EM, Asmawidjaja PS, van Hamburg JP, et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2010;62:132\u2013142.","journal-title":"Arthritis Rheum"},{"key":"5351_CR189","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2006.07.008","volume":"103","author":"M Stio","year":"2007","unstructured":"Stio M, Martinesi M, Bruni S, et al. The vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn\u2019s disease. J Steroid Biochem Mol Biol. 2007;103:51\u201360.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR190","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0955-0674(99)00075-7","volume":"12","author":"SM Keyse","year":"2000","unstructured":"Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000;12:186\u2013192.","journal-title":"Curr Opin Cell Biol"},{"key":"5351_CR191","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1038\/sj.onc.1210412","volume":"26","author":"DM Owens","year":"2007","unstructured":"Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene. 2007;26:3203\u20133213.","journal-title":"Oncogene"},{"key":"5351_CR192","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153\u2013183.","journal-title":"Endocr Rev"},{"key":"5351_CR193","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/cyto.2002.0895","volume":"20","author":"M Kracht","year":"2002","unstructured":"Kracht M, Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine. 2002;20:91\u2013106.","journal-title":"Cytokine"},{"key":"5351_CR194","doi-asserted-by":"publisher","first-page":"e78170","DOI":"10.1371\/journal.pone.0078170","volume":"8","author":"J Ryynanen","year":"2013","unstructured":"Ryynanen J, Carlberg C. Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells. PLoS ONE. 2013;8:e78170.","journal-title":"PLoS ONE"},{"key":"5351_CR195","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1172\/JCI30142","volume":"117","author":"J Schauber","year":"2007","unstructured":"Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117:803\u2013811.","journal-title":"J Clin Invest"},{"key":"5351_CR196","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1073\/pnas.92.24.10990","volume":"92","author":"XP Yu","year":"1995","unstructured":"Yu XP, Bellido T, Manolagas SC. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA. 1995;92:10990\u201310994.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5351_CR197","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1432-1033.1997.00063.x","volume":"250","author":"H Harant","year":"1997","unstructured":"Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Eur J Biochem. 1997;250:63\u201371.","journal-title":"Eur J Biochem"},{"key":"5351_CR198","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/eji.200425995","volume":"36","author":"K Sadeghi","year":"2006","unstructured":"Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361\u2013370.","journal-title":"Eur J Immunol"},{"key":"5351_CR199","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/apt.12825","volume":"40","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Aliment Pharmacol Ther. 2014;40:261\u2013279.","journal-title":"Aliment Pharmacol Ther"},{"key":"5351_CR200","doi-asserted-by":"publisher","first-page":"14544","DOI":"10.1074\/jbc.M112.427054","volume":"288","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Leung DY, Goleva E. Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J Biol Chem. 2013;288:14544\u201314553.","journal-title":"J Biol Chem"},{"key":"5351_CR201","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/cs0940557","volume":"94","author":"PJ Barnes","year":"1998","unstructured":"Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998;94:557\u2013572.","journal-title":"Clin Sci (Lond)"},{"key":"5351_CR202","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1093\/emboj\/20.24.7108","volume":"20","author":"O Kassel","year":"2001","unstructured":"Kassel O, Sancono A, Kratzschmar J, et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001;20:7108\u20137116.","journal-title":"EMBO J"},{"key":"5351_CR203","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1074\/jbc.M109.037309","volume":"285","author":"CR Tchen","year":"2010","unstructured":"Tchen CR, Martins JR, Paktiawal N, et al. Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J Biol Chem. 2010;285:2642\u20132652.","journal-title":"J Biol Chem"},{"key":"5351_CR204","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/joe.0.1780005","volume":"178","author":"AR Clark","year":"2003","unstructured":"Clark AR. MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol. 2003;178:5\u201312.","journal-title":"J Endocrinol"},{"key":"5351_CR205","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1471-4892(03)00073-0","volume":"3","author":"AR Clark","year":"2003","unstructured":"Clark AR, Lasa M. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol. 2003;3:404\u2013411.","journal-title":"Curr Opin Pharmacol"},{"key":"5351_CR206","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0165-5728(00)00297-6","volume":"109","author":"K Bosscher De","year":"2000","unstructured":"De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol. 2000;109:16\u201322.","journal-title":"J Neuroimmunol"},{"key":"5351_CR207","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1440-1711.2001.01025.x","volume":"79","author":"IM Adcock","year":"2001","unstructured":"Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol. 2001;79:376\u2013384.","journal-title":"Immunol Cell Biol"},{"key":"5351_CR208","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1210\/er.2002-0006","volume":"24","author":"K Bosscher De","year":"2003","unstructured":"De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev. 2003;24:488\u2013522.","journal-title":"Endocr Rev"},{"key":"5351_CR209","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1007\/s10620-016-4247-6","volume":"61","author":"AJ Czaja","year":"2016","unstructured":"Czaja AJ. Nature and implications of oxidative and nitrosative stresses in autoimmune hepatitis. Dig Dis Sci. 2016;61:2784\u20132803. https:\/\/doi.org\/10.1007\/s10620-016-4247-6 .","journal-title":"Dig Dis Sci"},{"key":"5351_CR210","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1104\/pp.110.167569","volume":"155","author":"CH Foyer","year":"2011","unstructured":"Foyer CH, Noctor G. Ascorbate and glutathione: the heart of the redox hub. Plant Physiol. 2011;155:2\u201318.","journal-title":"Plant Physiol"},{"key":"5351_CR211","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/abbi.1994.1444","volume":"314","author":"CC Winterbourn","year":"1994","unstructured":"Winterbourn CC, Metodiewa D. The reaction of superoxide with reduced glutathione. Arch Biochem Biophys. 1994;314:284\u2013290.","journal-title":"Arch Biochem Biophys"},{"key":"5351_CR212","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nchembio.85","volume":"4","author":"CC Winterbourn","year":"2008","unstructured":"Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol. 2008;4:278\u2013286.","journal-title":"Nat Chem Biol"},{"key":"5351_CR213","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0168-8278(02)00266-0","volume":"37","author":"P Sanz-Cameno","year":"2002","unstructured":"Sanz-Cameno P, Medina J, Garcia-Buey L, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol. 2002;37:723\u2013729.","journal-title":"J Hepatol"},{"key":"5351_CR214","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbadis.2004.01.005","volume":"1689","author":"PW Pemberton","year":"2004","unstructured":"Pemberton PW, Aboutwerat A, Smith A, et al. Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis? Biochim Biophys Acta. 2004;1689:182\u2013189.","journal-title":"Biochim Biophys Acta"},{"key":"5351_CR215","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsbmb.2010.01.001","volume":"119","author":"JN Artaza","year":"2010","unstructured":"Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010;119:73\u201383.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR216","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601\u2013613.","journal-title":"Cell"},{"key":"5351_CR217","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2009.11.004","volume":"118","author":"AM Ramirez","year":"2010","unstructured":"Ramirez AM, Wongtrakool C, Welch T, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118:142\u2013150.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR218","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","volume":"64","author":"A Beilfuss","year":"2015","unstructured":"Beilfuss A, Sowa JP, Sydor S, et al. Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 2015;64:791\u2013799.","journal-title":"Gut"},{"key":"5351_CR219","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/liv.12122","volume":"33","author":"JJ Potter","year":"2013","unstructured":"Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human alpha1 (I) collagen expression and type I collagen formation. Liver Int. 2013;33:677\u2013686.","journal-title":"Liver Int"},{"key":"5351_CR220","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/JOE-08-0241","volume":"200","author":"JN Artaza","year":"2009","unstructured":"Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol. 2009;200:207\u2013221.","journal-title":"J Endocrinol"},{"key":"5351_CR221","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12072-014-9548-2","volume":"8","author":"K Hochrath","year":"2014","unstructured":"Hochrath K, Stokes CS, Geisel J, et al. Vitamin D modulates biliary fibrosis in ABCB4-deficient mice. Hepatol Int. 2014;8:443\u2013452.","journal-title":"Hepatol Int"},{"key":"5351_CR222","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(05)78933-9","volume":"351","author":"A Malabanan","year":"1998","unstructured":"Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805\u2013806.","journal-title":"Lancet"},{"key":"5351_CR223","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","volume":"84","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18\u201328.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR224","doi-asserted-by":"publisher","first-page":"1080S","DOI":"10.1093\/ajcn\/87.4.1080S","volume":"87","author":"MF Holick","year":"2008","unstructured":"Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S\u20131086S.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR225","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1453356","author":"AJ Czaja","year":"2018","unstructured":"Czaja AJ. Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Rev Gastroenterol Hepatol. 2018. https:\/\/doi.org\/10.1080\/17474124.2018.1453356 .","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5351_CR226","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/apt.12731","volume":"39","author":"F Finkelmeier","year":"2014","unstructured":"Finkelmeier F, Kronenberger B, Koberle V, et al. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma\u2014a prospective cohort study. Aliment Pharmacol Ther. 2014;39:1204\u20131212.","journal-title":"Aliment Pharmacol Ther"},{"key":"5351_CR227","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1681\/ASN.V8101546","volume":"8","author":"E Fernandez","year":"1997","unstructured":"Fernandez E, Fibla J, Betriu A, et al. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol. 1997;8:1546\u20131552.","journal-title":"J Am Soc Nephrol"},{"key":"5351_CR228","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jhep.2009.03.005","volume":"50","author":"L Adorini","year":"2009","unstructured":"Adorini L. Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection? J Hepatol. 2009;50:1071\u20131073.","journal-title":"J Hepatol"},{"key":"5351_CR229","doi-asserted-by":"publisher","first-page":"38151","DOI":"10.1074\/jbc.M406373200","volume":"279","author":"AD Conigrave","year":"2004","unstructured":"Conigrave AD, Mun HC, Delbridge L, et al. l-amino acids regulate parathyroid hormone secretion. J Biol Chem. 2004;279:38151\u201338159.","journal-title":"J Biol Chem"},{"key":"5351_CR230","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00125-008-1061-5","volume":"51","author":"SB Mohr","year":"2008","unstructured":"Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. 2008;51:1391\u20131398.","journal-title":"Diabetologia"},{"key":"5351_CR231","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","volume":"82","author":"S Simpson Jr","year":"2011","unstructured":"Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:1132\u20131141.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5351_CR232","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/CLEP.S59838","volume":"6","author":"A Szilagyi","year":"2014","unstructured":"Szilagyi A, Leighton H, Burstein B, Xue X. Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model. Clin Epidemiol. 2014;6:183\u2013198.","journal-title":"Clin Epidemiol"},{"key":"5351_CR233","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ane.12040","volume":"126","author":"O Torkildsen","year":"2012","unstructured":"Torkildsen O, Grytten N, Aarseth J, Myhr KM, Kampman MT. Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurol Scand Suppl. 2012;126:58\u201362.","journal-title":"Acta Neurol Scand Suppl"},{"key":"5351_CR234","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/jnnp-2012-303934","volume":"84","author":"R Dobson","year":"2013","unstructured":"Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84:427\u2013432.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5351_CR235","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1096\/fj.201700062","volume":"31","author":"JD Reynolds","year":"2017","unstructured":"Reynolds JD, Case LK, Krementsov DN, et al. Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis. FASEB J. 2017;31:2709\u20132719.","journal-title":"FASEB J"},{"key":"5351_CR236","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","volume":"20","author":"A Mithal","year":"2009","unstructured":"Mithal A, Wahl DA, Bonjour JP, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807\u20131820.","journal-title":"Osteoporos Int"},{"key":"5351_CR237","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","volume":"82","author":"A Watad","year":"2017","unstructured":"Watad A, Azrielant S, Bragazzi NL, et al. Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity. J Autoimmun. 2017;82:13\u201330.","journal-title":"J Autoimmun"},{"key":"5351_CR238","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","volume":"62","author":"AJ Czaja","year":"2017","unstructured":"Czaja AJ. Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis. Dig Dis Sci. 2017;62:2277\u20132292. https:\/\/doi.org\/10.1007\/s10620-017-4675-y .","journal-title":"Dig Dis Sci"},{"key":"5351_CR239","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","volume":"14","author":"JS Delgado","year":"2013","unstructured":"Delgado JS, Vodonos A, Malnick S, et al. Autoimmune hepatitis in southern Israel: a 15-year multicenter study. J Dig Dis. 2013;14:611\u2013618.","journal-title":"J Dig Dis"},{"key":"5351_CR240","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","volume":"97","author":"KJ Hurlburt","year":"2002","unstructured":"Hurlburt KJ, McMahon BJ, Deubner H, et al. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002;97:2402\u20132407.","journal-title":"Am J Gastroenterol"},{"key":"5351_CR241","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4065\/81.3.353","volume":"81","author":"MF Holick","year":"2006","unstructured":"Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353\u2013373.","journal-title":"Mayo Clin Proc"},{"key":"5351_CR242","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s001980050030","volume":"7","author":"MC Chapuy","year":"1997","unstructured":"Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7:439\u2013443.","journal-title":"Osteoporos Int"},{"key":"5351_CR243","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0002-9343(02)01091-4","volume":"112","author":"V Tangpricha","year":"2002","unstructured":"Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112:659\u2013662.","journal-title":"Am J Med"},{"key":"5351_CR244","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jaad.2007.03.004","volume":"57","author":"LA Armas","year":"2007","unstructured":"Armas LA, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol. 2007;57:588\u2013593.","journal-title":"J Am Acad Dermatol"},{"key":"5351_CR245","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/ajcn\/67.6.1232","volume":"67","author":"SS Harris","year":"1998","unstructured":"Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998;67:1232\u20131236.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR246","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.5740\/jaoacint.17-0250","volume":"100","author":"SPJ Brooks","year":"2017","unstructured":"Brooks SPJ, Greene-Finestone L, Whiting S, et al. An analysis of factors associated with 25-hydroxyvitamin D levels in white and non-white Canadians. J AOAC Int. 2017;100:1345\u20131354.","journal-title":"J AOAC Int"},{"key":"5351_CR247","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1017\/S0007114518000491","volume":"119","author":"X Liu","year":"2018","unstructured":"Liu X, Baylin A, Levy PD. Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications. Br J Nutr. 2018;119:928\u2013936.","journal-title":"Br J Nutr"},{"key":"5351_CR248","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1191\/096120399678847704","volume":"8","author":"GS Alarcon","year":"1999","unstructured":"Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999;8:197\u2013209.","journal-title":"Lupus"},{"key":"5351_CR249","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/hep.21884","volume":"46","author":"S Verma","year":"2007","unstructured":"Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007;46:1828\u20131835.","journal-title":"Hepatology"},{"key":"5351_CR250","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1586\/egh.13.21","volume":"7","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol. 2013;7:365\u2013385.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5351_CR251","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1172\/JCI112134","volume":"76","author":"J MacLaughlin","year":"1985","unstructured":"MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536\u20131538.","journal-title":"J Clin Invest"},{"key":"5351_CR252","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1759720X17692502","volume":"9","author":"TR Hill","year":"2017","unstructured":"Hill TR, Aspray TJ. The role of vitamin D in maintaining bone health in older people. Ther Adv Musculoskelet Dis. 2017;9:89\u201395.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5351_CR253","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI107461","volume":"52","author":"P Ireland","year":"1973","unstructured":"Ireland P, Fordtran JS. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest. 1973;52:2672\u20132681.","journal-title":"J Clin Invest"},{"key":"5351_CR254","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jbmr.5650040404","volume":"4","author":"RP Heaney","year":"1989","unstructured":"Heaney RP, Recker RR, Stegman MR, Moy AJ. Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J Bone Miner Res. 1989;4:469\u2013475.","journal-title":"J Bone Miner Res"},{"key":"5351_CR255","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jbmr.5650060205","volume":"6","author":"R Eastell","year":"1991","unstructured":"Eastell R, Yergey AL, Vieira NE, et al. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res. 1991;6:125\u2013132.","journal-title":"J Bone Miner Res"},{"key":"5351_CR256","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ageing\/afs186","volume":"42","author":"C Mathei","year":"2013","unstructured":"Mathei C, Van Pottelbergh G, Vaes B, et al. No relation between vitamin D status and physical performance in the oldest old: results from the Belfrail study. Age Ageing. 2013;42:186\u2013190.","journal-title":"Age Ageing"},{"key":"5351_CR257","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/GME.0000000000001103","volume":"25","author":"MS Vallejo","year":"2018","unstructured":"Vallejo MS, Blumel JE, Lavin P, et al. Older women do not have seasonal variations of vitamin D levels: a study from a southern country. Menopause. 2018;25:912\u2013917.","journal-title":"Menopause"},{"key":"5351_CR258","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","volume":"96","author":"C Schramm","year":"2001","unstructured":"Schramm C, Kanzler S, Zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol. 2001;96:1587\u20131591.","journal-title":"Am J Gastroenterol"},{"key":"5351_CR259","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","volume":"45","author":"T Al-Chalabi","year":"2006","unstructured":"Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006;45:575\u2013583.","journal-title":"J Hepatol"},{"key":"5351_CR260","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/hep.21074","volume":"43","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006;43:532\u2013538.","journal-title":"Hepatology"},{"key":"5351_CR261","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.hepres.2006.06.007","volume":"36","author":"T Miyake","year":"2006","unstructured":"Miyake T, Miyaoka H, Abe M, et al. Clinical characteristics of autoimmune hepatitis in older aged patients. Hepatol Res. 2006;36:139\u2013142.","journal-title":"Hepatol Res"},{"key":"5351_CR262","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","volume":"21","author":"C Verslype","year":"2005","unstructured":"Verslype C, George C, Buchel E, et al. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther. 2005;21:695\u2013699.","journal-title":"Aliment Pharmacol Ther"},{"key":"5351_CR263","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","volume":"60","author":"L Gronbaek","year":"2014","unstructured":"Gronbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60:612\u2013617.","journal-title":"J Hepatol"},{"key":"5351_CR264","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","volume":"25","author":"JH Ngu","year":"2010","unstructured":"Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010;25:1681\u20131686.","journal-title":"J Gastroenterol Hepatol"},{"key":"5351_CR265","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF02555135","volume":"43","author":"Y Liel","year":"1988","unstructured":"Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43:199\u2013201.","journal-title":"Calcif Tissue Int"},{"key":"5351_CR266","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","volume":"72","author":"J Wortsman","year":"2000","unstructured":"Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690\u2013693.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR267","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2002-020978","volume":"88","author":"S Arunabh","year":"2003","unstructured":"Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157\u2013161.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR268","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00394-008-0700-4","volume":"47","author":"S Konradsen","year":"2008","unstructured":"Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008;47:87\u201391.","journal-title":"Eur J Nutr"},{"key":"5351_CR269","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3945\/ajcn.115.120139","volume":"103","author":"JS Walsh","year":"2016","unstructured":"Walsh JS, Evans AL, Bowles S, et al. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr. 2016;103:1465\u20131471.","journal-title":"Am J Clin Nutr"},{"key":"5351_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.02.024","author":"S Delle Monache","year":"2018","unstructured":"Delle Monache S, Di Fulvio P, Iannetti E, et al. Body mass index represents a good predictor of vitamin D status in women independently from age. Clin Nutr. 2018. https:\/\/doi.org\/10.1016\/j.clnu.2018.02.024 .","journal-title":"Clin Nutr"},{"key":"5351_CR271","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41430-018-0086-1","volume":"72","author":"M Tabesh","year":"2018","unstructured":"Tabesh M, Callegari ET, Gorelik A, et al. Associations between 25-hydroxyvitamin D levels, body composition and metabolic profiles in young women. Eur J Clin Nutr. 2018;72:1093\u20131102.","journal-title":"Eur J Clin Nutr"},{"key":"5351_CR272","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1210\/jc.2012-4103","volume":"98","author":"A Drincic","year":"2013","unstructured":"Drincic A, Fuller E, Heaney RP, Armas LA. 25-Hydroxyvitamin D response to graded vitamin D(3) supplementation among obese adults. J Clin Endocrinol Metab. 2013;98:4845\u20134851.","journal-title":"J Clin Endocrinol Metab"},{"key":"5351_CR273","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jsbmb.2012.12.003","volume":"136","author":"JC Gallagher","year":"2013","unstructured":"Gallagher JC, Yalamanchili V, Smith LM. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol. 2013;136:195\u2013200.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR274","doi-asserted-by":"publisher","first-page":"e0192596","DOI":"10.1371\/journal.pone.0192596","volume":"13","author":"E Saarnio","year":"2018","unstructured":"Saarnio E, Pekkinen M, Itkonen ST, et al. Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone? PLoS ONE. 2018;13:e0192596.","journal-title":"PLoS ONE"},{"key":"5351_CR275","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/oby.2011.404","volume":"20","author":"AT Drincic","year":"2012","unstructured":"Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444\u20131448.","journal-title":"Obesity (Silver Spring)"},{"key":"5351_CR276","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00394-013-0524-8","volume":"53","author":"T Karlsson","year":"2014","unstructured":"Karlsson T, Osmancevic A, Jansson N, et al. Increased vitamin D-binding protein and decreased free 25(OH)D in obese women of reproductive age. Eur J Nutr. 2014;53:259\u2013267.","journal-title":"Eur J Nutr"},{"key":"5351_CR277","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00198-011-1737-4","volume":"23","author":"K Uusi-Rasi","year":"2012","unstructured":"Uusi-Rasi K, Laaksonen M, Mikkila V, et al. Overweight in childhood and bone density and size in adulthood. Osteoporos Int. 2012;23:1453\u20131461.","journal-title":"Osteoporos Int"},{"key":"5351_CR278","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jbmr.2017","volume":"29","author":"H Johansson","year":"2014","unstructured":"Johansson H, Kanis JA, Oden A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014;29:223\u2013233.","journal-title":"J Bone Miner Res"},{"key":"5351_CR279","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1024\/0300-9831\/a000426","volume":"86","author":"SF Mahmood","year":"2018","unstructured":"Mahmood SF, Idiculla J, Joshi R, Joshi S, Kulkarni S. Vitamin D supplementation in adults with vitamin D deficiency and its effect on metabolic syndrome\u2014a randomized controlled study. Int J Vitam Nutr Res. 2018;86:121\u2013126.","journal-title":"Int J Vitam Nutr Res"},{"key":"5351_CR280","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/oby.22132","volume":"26","author":"CMA Cefalo","year":"2018","unstructured":"Cefalo CMA, Conte C, Sorice GP, et al. Effect of vitamin D supplementation on obesity-induced insulin resistance: a double-blind, randomized, placebo-controlled trial. Obesity (Silver Spring). 2018;26:651\u2013657.","journal-title":"Obesity (Silver Spring)"},{"key":"5351_CR281","doi-asserted-by":"publisher","first-page":"e0177722","DOI":"10.1371\/journal.pone.0177722","volume":"12","author":"JM Seong","year":"2017","unstructured":"Seong JM, Yoon YS, Lee KS, et al. Gender difference in relationship between serum ferritin and 25-hydroxyvitamin D in Korean adults. PLoS ONE. 2017;12:e0177722.","journal-title":"PLoS ONE"},{"key":"5351_CR282","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.4049\/jimmunol.0901351","volume":"183","author":"FE Nashold","year":"2009","unstructured":"Nashold FE, Spach KM, Spanier JA, Hayes CE. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol. 2009;183:3672\u20133681.","journal-title":"J Immunol"},{"key":"5351_CR283","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1352458508095920","volume":"15","author":"J Kragt","year":"2009","unstructured":"Kragt J, van Amerongen B, Killestein J, et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler. 2009;15:9\u201315.","journal-title":"Mult Scler"},{"key":"5351_CR284","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.175.6.4119","volume":"175","author":"KM Spach","year":"2005","unstructured":"Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol. 2005;175:4119\u20134126.","journal-title":"J Immunol"},{"key":"5351_CR285","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5:463\u2013466.","journal-title":"Curr Opin HIV AIDS"},{"key":"5351_CR286","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2010.07.002","volume":"134","author":"U Ikeda","year":"2010","unstructured":"Ikeda U, Wakita D, Ohkuri T, et al. 1alpha,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett. 2010;134:7\u201316.","journal-title":"Immunol Lett"},{"key":"5351_CR287","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/pr200724e","volume":"11","author":"GB Ferreira","year":"2012","unstructured":"Ferreira GB, Kleijwegt FS, Waelkens E, et al. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res. 2012;11:941\u2013971.","journal-title":"J Proteome Res"},{"key":"5351_CR288","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","volume":"16","author":"B Dawson-Hughes","year":"2005","unstructured":"Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713\u2013716.","journal-title":"Osteoporos Int"},{"key":"5351_CR289","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"5351_CR290","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-3-642-55580-0_25","volume":"164","author":"R Bouillon","year":"2003","unstructured":"Bouillon R, Verstuyf A, Verlinden L, Eelen G, Mathieu C. Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Recent Results Cancer Res. 2003;164:353\u2013356.","journal-title":"Recent Results Cancer Res"},{"key":"5351_CR291","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fphys.2014.00122","volume":"5","author":"C Leyssens","year":"2014","unstructured":"Leyssens C, Verlinden L, Verstuyf A. The future of vitamin D analogs. Front Physiol. 2014;5:122.","journal-title":"Front Physiol"},{"key":"5351_CR292","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00024677-200201050-00004","volume":"1","author":"AJ Brown","year":"2002","unstructured":"Brown AJ, Coyne DW. Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism. Treat Endocrinol. 2002;1:313\u2013327.","journal-title":"Treat Endocrinol"},{"key":"5351_CR293","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1124\/mol.104.008730","volume":"67","author":"G Eelen","year":"2005","unstructured":"Eelen G, Verlinden L, Rochel N, et al. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol. 2005;67:1566\u20131573.","journal-title":"Mol Pharmacol"},{"key":"5351_CR294","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jsbmb.2012.10.009","volume":"136","author":"GB Ferreira","year":"2013","unstructured":"Ferreira GB, Overbergh L, Verstuyf A, Mathieu C. 1alpha,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. J Steroid Biochem Mol Biol. 2013;136:160\u2013165.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR295","first-page":"2673","volume":"60","author":"L Verlinden","year":"2000","unstructured":"Verlinden L, Verstuyf A, Van Camp M, et al. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res. 2000;60:2673\u20132679.","journal-title":"Cancer Res"},{"key":"5351_CR296","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0003-9861(84)90161-9","volume":"229","author":"Y Tanaka","year":"1984","unstructured":"Tanaka Y, DeLuca HF, Kobayashi Y, Ikekawa N. 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. Arch Biochem Biophys. 1984;229:348\u2013354.","journal-title":"Arch Biochem Biophys"},{"key":"5351_CR297","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5414\/CNP71660","volume":"71","author":"H Ito","year":"2009","unstructured":"Ito H, Ogata H, Yamamoto M, et al. Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephrol. 2009;71:660\u2013668.","journal-title":"Clin Nephrol"},{"key":"5351_CR298","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000420171","volume":"91","author":"S Okamoto","year":"1991","unstructured":"Okamoto S, Ejima E, Kiriyama T, et al. Mechanism of action of newly developed vitamin D analogue. Contrib Nephrol. 1991;91:146\u2013148.","journal-title":"Contrib Nephrol"},{"key":"5351_CR299","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133\u2013146.","journal-title":"Nat Rev Immunol"},{"key":"5351_CR300","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V95.10.3183","volume":"95","author":"KS Wang","year":"2000","unstructured":"Wang KS, Frank DA, Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood. 2000;95:3183\u20133190.","journal-title":"Blood"},{"key":"5351_CR301","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jsbmb.2015.05.012","volume":"152","author":"M Bhat","year":"2015","unstructured":"Bhat M, Ismail A. Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol. 2015;152:171\u2013179.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5351_CR302","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s13105-014-0335-2","volume":"70","author":"AA Seif","year":"2014","unstructured":"Seif AA, Abdelwahed DM. Vitamin D ameliorates hepatic ischemic\/reperfusion injury in rats. J Physiol Biochem. 2014;70:659\u2013666.","journal-title":"J Physiol Biochem"},{"key":"5351_CR303","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1024\/0300-9831\/a000156","volume":"83","author":"A Gren","year":"2013","unstructured":"Gren A. Effects of vitamin E, C and D supplementation on inflammation and oxidative stress in streptozotocin-induced diabetic mice. Int J Vitam Nutr Res. 2013;83:168\u2013175.","journal-title":"Int J Vitam Nutr Res"},{"key":"5351_CR304","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00198-018-4520-y","volume":"29","author":"JM Quesada-Gomez","year":"2018","unstructured":"Quesada-Gomez JM, Bouillon R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int. 2018;29:1697\u20131711.","journal-title":"Osteoporos Int"},{"key":"5351_CR305","first-page":"169","volume":"6","author":"L Cavalli","year":"2009","unstructured":"Cavalli L, Cavalli T, Marcucci G, et al. Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women. Clin Cases Miner Bone Metab. 2009;6:169\u2013173.","journal-title":"Clin Cases Miner Bone Metab"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5351-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5351-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:08:34Z","timestamp":1775254114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5351-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,28]]},"references-count":305,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5351"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5351-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,28]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This review did not receive financial support from a funding agency or institution, and Albert J. Czaja, MD and Aldo J. Montano-Loza, MD, PhD have no conflict of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}